The agency has added a COVID-19 innovation resource page and an education resources page to its website.
To provide the public with information regarding COVID-19, FDA has created two web pages on its website: "Innovation to Respond to COVID-19" and "Educational Resources". Innovation to Respond to COVID-19 lists FDA’s innovative approaches to respond to COVID-19. It provides updates to connect manufacturers and healthcare entities, analysis of real-world data, the Coronavirus Treatment Acceleration Program, and guidance documents that promote innovation. Educational Resources provides links to COVID-19-related resources that help explain FDA’s work, including videos, a social media kit, consumer articles, and more.
Source: FDA
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.